Studies of ex vivo activated and expanded CD8+ NK-T cells in humans and mice.
about
Cell-based Immunotherapy for Colorectal Cancer with Cytokine-induced Killer CellsAdoptive immunotherapy for acute leukemia: New insights in chimeric antigen receptorsAdoptive Cell Therapy of Melanoma with Cytokine-induced Killer CellsMDSC-decreasing chemotherapy increases the efficacy of cytokine-induced killer cell immunotherapy in metastatic renal cell carcinoma and pancreatic cancer.In vivo trafficking and survival of cytokine-induced killer cells resulting in minimal GVHD with retention of antitumor activityEnhancing cytokine-induced killer cell therapy of multiple myeloma.Early efficacy of stereotactic body radiation therapy combined with adoptive immunotherapy for advanced malignanciesEngineering antiphagocytic biomimetic drug carriers.Preclinical and clinical studies on cytokine-induced killer cells for the treatment of renal cell carcinoma.Chimeric antigen receptor-engineered cytokine-induced killer cells overcome treatment resistance of pre-B-cell acute lymphoblastic leukemia and enhance survival.Cytokine-induced killer cells for cell therapy of acute myeloid leukemia: improvement of their immune activity by expression of CD33-specific chimeric receptors.Analysis of adverse events following the treatment of autologous cytokine-induced killer cells for adoptive immunotherapy in malignant tumour sufferers.Analytic and Dynamic Secretory Profile of Patient-Derived Cytokine-Induced Killer Cells.Improved activation toward primary colorectal cancer cells by antigen-specific targeting autologous cytokine-induced killer cells.Natural killer T cells subsets in cancer, functional defects in prostate cancer and implications for immunotherapy.Protein kinase C is involved in 2B4 (CD244)-mediated cytotoxicity and AP-1 activation in natural killer cells.Efficient killing of radioresistant breast cancer cells by cytokine-induced killer cells.Immunotherapy of B-cell malignancies with genetically engineered human CD8+ natural killer T cells.Cytokine Induced Killer cells are effective against sarcoma cancer stem cells spared by chemotherapy and target therapy
P2860
Q26751018-79DEA120-1A0E-446D-8E48-8EA44A857A7DQ26795540-C423C868-71CD-467C-ACD5-E392E5DFF042Q35543911-24B3071C-41A3-419D-805A-279EA24C5D7FQ36782579-34297290-18D4-48D2-B493-7F47D6C1CE7AQ36868792-B07E1356-8C74-490F-9FCB-CA7D1B51039EQ36892290-628E2BA1-F4B7-496B-B36A-E624564B76F3Q37560863-FC63D228-5BCD-46F9-8C00-EBB0B8D25F00Q38123856-C212F40B-5888-4824-8457-FFFA36457D71Q38201328-3B59B206-E87E-466A-A59E-9D0E921E93A7Q38767030-03329217-5622-4906-B3AB-2E4666AB7A30Q39667028-6E34FD41-E3D8-424D-97CE-DA27D7234474Q40180859-7CB2CC66-ABB0-4825-8436-6F0E01E465A3Q42274903-1994EAF7-D21A-4400-A4D5-E422324FC14EQ42573170-E6722D52-DB39-4667-BBD7-6048E4509B8FQ42579685-1D6237A1-2906-499B-81B4-9BBA19576718Q44478572-04FC55C5-862F-462C-855C-D3BBF9EB3BC4Q50667533-D46CC2F9-F2A2-4C3E-A447-E15E32509F69Q51281953-77787AE7-EABF-4AE3-9CDB-57B07C4919E1Q58566155-99FB1E2A-DB68-427B-89AD-5A8EBF1D63BC
P2860
Studies of ex vivo activated and expanded CD8+ NK-T cells in humans and mice.
description
2002 nî lūn-bûn
@nan
2002 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Studies of ex vivo activated and expanded CD8+ NK-T cells in humans and mice.
@ast
Studies of ex vivo activated and expanded CD8+ NK-T cells in humans and mice.
@en
Studies of ex vivo activated and expanded CD8+ NK-T cells in humans and mice.
@nl
type
label
Studies of ex vivo activated and expanded CD8+ NK-T cells in humans and mice.
@ast
Studies of ex vivo activated and expanded CD8+ NK-T cells in humans and mice.
@en
Studies of ex vivo activated and expanded CD8+ NK-T cells in humans and mice.
@nl
prefLabel
Studies of ex vivo activated and expanded CD8+ NK-T cells in humans and mice.
@ast
Studies of ex vivo activated and expanded CD8+ NK-T cells in humans and mice.
@en
Studies of ex vivo activated and expanded CD8+ NK-T cells in humans and mice.
@nl
P2093
P356
P1476
Studies of ex vivo activated and expanded CD8+ NK-T cells in humans and mice.
@en
P2093
Jeanette Baker
Matthias Edinger
Michael R Verneris
Robert S Negrin
P2888
P304
P356
10.1023/A:1015415928521
P577
2002-05-01T00:00:00Z
P6179
1029034383